The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
but it's you know interesting to note but if a woman is very high risk like has ascbd and we're trying to Target these really intensive thresholds like ldls less than 70 or even lower it's useful to know that they do change throughout the menstrual cycle
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so while there's no specific guidance around this you know I generally recommend clinicians measure the lipid panel during the Menses so that it's ideally measured monitored and compared at the same time during the menstrual cycle so usually the Menses is easiest to Benchmark to